AU Stock MarketDetailed Quotes
COV Cleo Diagnostics Ltd
- 0.355
- +0.005+1.43%
20min DelayNot Open Oct 4 16:00 AET
45.62MMarket Cap-11093P/E (Static)
0.365High0.350Low51.70KVolume0.360Open0.350Pre Close18.15KTurnover0.48052wk High0.07%Turnover Ratio128.50MShares0.14052wk Low-0.032EPS TTM25.92MFloat Cap0.480Historical HighLossP/E (Static)73.01MShs Float0.140Historical Low-0.032EPS LYR4.29%Amplitude--Dividend TTM4.86P/B1Lot Size--Div YieldTTM
Cleo Diagnostics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|
| Operating cash flow (direct method) | ||
| Cash income from operating activities | 210.81K | |
| Income from government grants | --210.81K | ---- |
| Cash paid | -278.37%-2.59M | -684.47K |
| Payments to suppliers for goods and services | -278.37%-2.59M | ---684.47K |
| Direct interest received | --348.82K | ---- |
| Operating cash flow | -196.61%-2.03M | ---684.47K |
| Investing cash flow | ||
| Cash flow from continuing investing activities | 99.10%-3.05K | -340.24K |
| Net PPE purchase and sale | 92.43%-3.05K | ---40.24K |
| Net intangibles purchas and sale | ---- | ---300K |
| Cash from discontinued investing activities | ||
| Investing cash flow | 99.10%-3.05K | ---340.24K |
| Financing cash flow | ||
| Cash flow from continuing financing activities | 813.97%11.17M | 1.22M |
| Net issuance payments of debt | ---- | --1.4M |
| Net common stock issuance | --11.17M | ---- |
| Net other financing activities | ---- | ---181.52K |
| Cash from discontinued financing activities | ||
| Financing cash flow | 813.97%11.17M | --1.22M |
| Net cash flow | ||
| Beginning cash position | 460.86%239.77K | --42.75K |
| Current changes in cash | 4,535.49%9.13M | --197.02K |
| End cash Position | 3,809.00%9.37M | --239.77K |
| Free cash from | -98.42%-2.03M | ---1.02M |
| Accounting Standards | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data